Prof. Dr. Andreas Mackensen

Lehrstuhl für Innere Medizin V

Mechanistic Characterization of Tafasitamab-Mediated Antibody-Dependent Cellular Phagocytosis Alone or in Combination with Lenalidomide (2019) Mougiakakos D, Völkl S, Bach C, Stoll A, Bitterer K, Beier F, Endell J, et al. Conference contribution Microenvironmental Triggers Induce a Chemoresistant, Differentiated Subset of S100A8/A9(high) AML Cells Via the Jak/STAT3 Signaling Axis (2019) Böttcher M, Panagiotidis K, Mentz K, Völkl S, Bruns H, Slany R, Mackensen A, Mougiakakos D Conference contribution Specific inhibition of PRMT5 suppresses human CD8+T cells by upregulation of p53 and impairment of the AKT pathway similar to the tumor metabolite MTA (2019) Strobl C, Schaffer S, Völkl S, Haug T, Peter K, Böttcher M, Mougiakakos D, et al. Conference contribution, Abstract of a poster Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY (2019) Kretschmann S, Herda S, Bruns H, Russ J, van der Meijden ED, Schlötzer-Schrehardt U, Griffioen M, et al. Journal article Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity (2019) Haug T, Aigner M, Peuser MM, Strobl C, Hildner K, Mougiakakos D, Bruns H, et al. Journal article Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines (2019) Kittler J, Sommer J, Fischer A, Britting S, Karg M, Bock B, Atreya I, et al. Journal article Efficient Elimination of Cells from Patients with Different AML Subtypes by Dual-Targeting Triplebody 33-16-123 (2019) Braciak T, Fenn N, Wildenhain S, Schiller C, Roskopf C, Schubert I, Jacob U, et al. Conference contribution Design and Implementation of a Single Source Multipurpose Hospital-Wide Clinical Trial Registry. (2019) Sommer M, Kirchner M, Gulden C, Egloffstein S, Lux MP, Beckmann M, Mackensen A, Prokosch HU Journal article Design and Implementation of a Single Source Multipurpose Hospital-Wide Clinical Trial Registry (2019) Sommer M, Kirchner M, Gulden C, Egloffstein S, Lux MP, Beckmann M, Mackensen A, Prokosch HU Conference contribution A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice (2019) Wagner F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution